BACE1 and liver dysplastic nodule: Furthermore, leveraging the canonical SMILES structure of NGR1 obtained from PubChem, we predicted its potential drug targets (Fig. 1D) and subsequently identified potential drug targets associated with glomerular injury in DN patients, such as VEGFA, FGF1, ITGB5, LGALS8, SLC5A2, and BACE1.